A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
BioNTech SE
BioNTech SE
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Eli Lilly and Company
Zhejiang Provincial People's Hospital
Genentech, Inc.
MOMA Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AbbVie
Iambic Therapeutics, Inc
National Cancer Institute (NCI)
OncoC4, Inc.
Revolution Medicines, Inc.
Exscientia AI Limited
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Seagen Inc.
Coherus Oncology, Inc.
Conjupro Biotherapeutics, Inc.
AstraZeneca
Arcus Biosciences, Inc.
Sotio Biotech Inc.
SillaJen, Inc.
ImmVirx Pty Ltd
EMD Serono
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GlaxoSmithKline
SystImmune Inc.
Rondo Therapeutics
Qilu Hospital of Shandong University
Institut Paoli-Calmettes
Arbele Limited
Washington University School of Medicine
Dong-A ST Co., Ltd.
Boehringer Ingelheim
I-Mab Biopharma US Limited
BeOne Medicines
Sutro Biopharma, Inc.
ViroMissile, Inc.
Seagen Inc.
Pfizer
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
ArriVent BioPharma, Inc.
NiKang Therapeutics, Inc.
Poseida Therapeutics, Inc.
Baylor College of Medicine
Jiangsu HengRui Medicine Co., Ltd.
MacroGenics